Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0001628280-25-055371 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | 2025-12-02 | SRTA | Verdetto Louis R. | CEO Keystone Perfusion Service | A - Grant | $0.00 | +63.9K | 1.13M | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2025-12-02 | A | A | 63,918 | $0.00 | 1,133,793 | D | — | — | (F1) Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 25% of the RSUs (rounded down to the nearest whole number) to become vested on September 8, 2026 and then 6.25% (rounded down to the nearest whole number) will vest every 3 months thereafter, with any remaining unvested RSUs to vest on September 8, 2029, subject to the Reporting Person's continued service to the Issuer. |